Processa Pharmaceuticals, Inc. (PCSA) SEC Filings — 2024

Filings

• Processa Pharmaceuticals Files S-1 — S-1 · Dec 20, 2024
• Processa Pharmaceuticals Changes Independent Auditor — 8-K · Nov 6, 2024
• Processa Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Oct 30, 2024
• Processa Pharmaceuticals Files 8-K — 8-K · Oct 2, 2024
• Processa Pharmaceuticals Files 8-K — 8-K · Aug 28, 2024
• Processa Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
• Processa Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Jul 30, 2024
• Processa Pharmaceuticals Elects New Director — 8-K · Jul 17, 2024
• Processa Pharmaceuticals Files 8-K on Shareholder Votes & Financials — 8-K · Jul 2, 2024
• Processa Pharmaceuticals Enters Material Definitive Agreement — 8-K · May 21, 2024
• Processa Pharmaceuticals Files 10-Q for Q1 2024 — 10-Q · May 10, 2024
• Processa Pharmaceuticals Announces 2024 Annual Meeting of Stockholders on June 28 — DEF 14A · Apr 29, 2024
• Processa Pharmaceuticals Files 8-K — 8-K · Apr 11, 2024
• Processa Pharmaceuticals Files 8-K with Corporate Updates — 8-K · Apr 4, 2024
• Processa Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• Processa Pharmaceuticals Files 8-K on Feb 20 Event — 8-K · Feb 21, 2024
• Processa Pharma Files 8-K, Confirms Nasdaq Listing & Corporate Details — 8-K · Feb 6, 2024
• Processa Pharma Reports Material Definitive Agreement; Details Undisclosed — 8-K · Jan 30, 2024
• Processa Pharma Files 8-K on Other Events, Financials — 8-K · Jan 25, 2024
• Processa Pharmaceuticals Files Amendment to S-1 Registration Statement — S-1/A · Jan 22, 2024
• Processa Pharma Files 8-K, Confirms Nasdaq Listing — 8-K · Jan 19, 2024
• Processa Pharma 8-K: Material Modifications to Security Holder Rights — 8-K · Jan 18, 2024
• Processa Pharma Files 8-K, Confirms Nasdaq Listing — 8-K · Jan 8, 2024